SolasCure

Founded in 2017, based out of United Kingdom, SolasCure Limited aims to support healthcare professionals with wound care products that significantly improve the health and wellbeing of patients with chronic wounds. SolasCures first product, Aurase is a hydrogel containing a safe, active, highly-specific enzyme, isolated and cloned from medical maggots. The medical use of Aurase should lead to faster wound cleaning promoting better patient outcomes and reduced healthcare costs.